Phase 3 Cardiac Disease Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Heparin vs Placebo for Cardiac Catheterization
Cardiac Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1,623 enrolled2 locationsNCT04374799
Recruiting
Phase 3
Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery
Inflammatory ResponseCardiac Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School768 enrolled1 locationNCT06118034
Recruiting
Phase 3
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Stroke, IschemicStrokeAtherosclerosis+5 more
Assistance Publique - Hôpitaux de Paris2,800 enrolled1 locationNCT05476991
Recruiting
Phase 3
Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac Echocardiography
Cardiac Diseases
Trust Bio-sonics, Inc.150 enrolled6 locationsNCT06815627